Steve Groskreutz came to Pitt in 2012, after graduating magna cum laude from Gustavus Adolphus College in Minnesota, where he did undergrad research with Dwight R. Stoll and received a 2011 Barry Goldwater fellowship. Here, he joined the Weber research group focusing on separations in HPLC, receiving a a Kenneth P. Dietrich School of Arts and Sciences Graduate Fellowship from 2012-2014, and a prestigious NSF Graduate Research Fellowship in 2014. In 2014, his third year, Steve published his first paper, received an Agilent Technologies Best Poster Award at the HPLC conference in New Orleans. The next year, he published three papers on a solute focusing technique, and was also selected as one of 55 representatives for the United States to the 65th Lindau Nobel Laureate Meeting in 2015. He graduated after 5 years at Pitt, giving research presentations at seven domestic and international technical conferences, and publishing 10 papers and a US patent.
While at Pitt, he did a research internship in Genentech’s Small Molecule Analytical Chemistry and Quality Control group in South San Francisco, which was critical to choosing to pursue an industrial career in the pharmaceutical industry. After receiving his Ph.D. in 2017 from Pitt, he accepted a position at Eli Lilly and Company in Indianapolis. Currently, he focuses on next generation manufacturing platforms in Lilly’s late stage development organization. Eventually this technology-focused role will grow into that of an analytical lead for molecules in Phase 2 and Phase 3 clinical trials. His role will be in direct support for the analytical needs of these projects from manufacturing to regulatory filings.
Steve's curriculum vitae.